The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection
Open accessAbstract
Regulatory T cell (Treg) therapy using recipient-derived Tregs expanded ex vivo is currently being investigated clinically by us and others as a means of reducing allograft rejection following organ transplantation. Data from animal models has demonstrated that adoptive transfer of allospecific Tregs offers greater protection from graft rejection compared to polyclonal Tregs. Chimeric antigen receptors (CAR) are clinically translatable synthetic fusion proteins that can redirect the specificity of T cells toward designated antigens. We used CAR technology to redirect human polyclonal Tregs toward donor-MHC class I molecules, which are ubiquitously expressed in allografts. Two novel HLA-A2-specific CARs were engineered: one comprising a CD28-CD3ζ signaling domain (CAR) and one lacking an intracellular signaling domain (ΔCAR). CAR Tregs were specifically activated and significantly more suppressive than polyclonal or ΔCAR Tregs in the presence of HLA-A2, without eliciting cytotoxic activity. Furthermore, CAR and ΔCAR Tregs preferentially transmigrated across HLA-A2-expressing endothelial cell monolayers. In a human skin xenograft transplant model, adoptive transfer of CAR Tregs alleviated the alloimmune-mediated skin injury caused by transferring allogeneic peripheral blood mononuclear cells more effectively than polyclonal Tregs. Our results demonstrated that the use of CAR technology is a clinically applicable refinement of Treg therapy for organ transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R. I., Cecchini, D., et al. (2011) · Blood · doi:10.1182/blood-2010-10-311894 · Cited by 1,064
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., et al. (2011) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,045
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., & Ley, T. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.014 · Cited by 1,035
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
Maher, J., Brentjens, R. J., Gunset, G., Rivière, I., & Sadelain, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-70 · Cited by 1,034
Self-citationType 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Savoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., Kamble, R. T., Bollard, C. M., Gee, A. P., Mei, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46110 · Cited by 1,023
Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death
Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., & Ley, T. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.002 · Cited by 1,020
Regulatory T cells: how do they suppress immune responses?
Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., & Yamaguchi, T. (2009) · International Immunology · doi:10.1093/intimm/dxp095 · Cited by 854
Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J., & Hellmann, A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.001 · Cited by 683
Finney, H. M., Lawson, A. D. G., Bebbington, C. R., & Weir, A. N. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2791 · Cited by 546
Till, B. G., Jensen, M. C., Wang, J., Qian, X., Gopal, A. K., Maloney, D. G., Lindgren, C. G., Lin, Y., Pagel, J. M., Budde, L. E., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387969 · Cited by 529
Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes
Joffre, O., Santolaria, T., Calise, D., Saati, T. A., Hudrisier, D., Romagnoli, P., & van Meerwijk, J. P. M. (2008) · Nature Medicine · doi:10.1038/nm1688 · Cited by 515
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82771 · Cited by 494
Marek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Derkowska, I., Juścińska, J., Owczuk, R., Szadkowska, A., Witkowski, P., Młynarski, W., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.03.016 · Cited by 384 · cited 1×
“With the safety of Treg therapy having been demonstrated in the contexts of graft-versus-host disease (GvHD) (23–26) and type I diabetes (27,28), we are conducting Phase I/II clinical trials to investigate the therapeutic potential of adoptive polyclonal Treg therapy to promote tolerance in kidney (The ONE Study: NCT0…”
Sagoo, P., Ali, N., Garg, G., Nestle, F. O., Lechler, R. I., & Lombardi, G. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002076 · Cited by 380
Self-citationCAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., Harris, R. A., Magnusson, P. U., Brittebo, E., & Loskog, A. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-112 · Cited by 372
Krause, A., Guo, H.-F., Latouche, J.-B., Tan, C., Cheung, N.-K. V., & Sadelain, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.619 · Cited by 365
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Barzaghi, F., Passerini, L., & Bacchetta, R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00211 · Cited by 325
Golshayan, D., Jiang, S., Tsang, J., Garin, M. I., Mottet, C., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-05-025460 · Cited by 313
Self-citationLouis, S., Braudeau, C., Giral, M., Dupont, A., Moizant, F., Robillard, N., Moreau, A., Soulillou, J.-P., & Brouard, S. (2006) · Transplantation · doi:10.1097/01.tp.0000203166.44968.86 · Cited by 277
Tsang, J. Y.-S., Tanriver, Y., Jiang, S., Xue, S.-A., Ratnasothy, K., Chen, D., Stauss, H. J., Bucy, R. P., Lombardi, G., & Lechler, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33185 · Cited by 271
Self-citationPutnam, A. L., Safinia, N., Medvec, A., Laszkowska, M., Wray, M., Mintz, M. A., Trotta, E., Szot, G. L., Liu, W., Lares, A., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12433 · Cited by 261
Self-citationThe current state of pancreas transplantation
Gruessner, R. W. G., & Gruessner, A. C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.138 · Cited by 256
Blat, D., Zigmond, E., Alteber, Z., Waks, T., & Eshhar, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2014.41 · Cited by 246
Pathways of allorecognition: implications for transplantation tolerance
Game, D. S., & Lechler, R. I. (2002) · Transplant Immunology · doi:10.1016/s0966-3274(02)00055-2 · Cited by 214
Self-citationRogers, N. J., & Lechler, R. I. (2001) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2001.10201.x · Cited by 201
Self-citationTheil, A., Tuve, S., Oelschlägel, U., Maiwald, A., Döhler, D., Oßmann, D., Zenkel, A., Wilhelm, C., Middeke, J. M., Shayegi, N., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.11.005 · Cited by 180
Marker succession during the development of keratinocytes from cultured human embryonic stem cells
Green, H., Easley, K., & Iuchi, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307226100 · Cited by 180
Elinav, E., Waks, T., & Eshhar, Z. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.060 · Cited by 180
Elinav, E., Adam, N., Waks, T., & Eshhar, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.049 · Cited by 168
Scottà, C., Esposito, M., Fazekasova, H., Fanelli, G. C., Edozie, F. C., Ali, N., Xiao, F., Peakman, M., Afzali, B., Sagoo, P., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.074088 · Cited by 151
Self-citationSafinia, N., Vaikunthanathan, T., Fraser, H., Thirkell, S., Lowe, K., Blackmore, L., Whitehouse, G. P., Martínez‐Llordella, M., Jassem, W., Fueyo, A. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6927 · Cited by 145
Self-citationLee, K., Nguyen, V. Q., Lee, K.-M., Kang, S., & Tang, Q. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12509 · Cited by 125
Kohn, D. B., Dotti, G., Brentjens, R. J., Savoldo, B., Jensen, M. C., Cooper, L. J. N., June, C. H., Rosenberg, S. A., Sadelain, M., & Heslop, H. E. (2011) · Molecular Therapy · doi:10.1038/mt.2011.1 · Cited by 117
Lee, J., Hayman, E. G., Pegram, H. J., Santos, E. B., Heller, G., Sadelain, M., & Brentjens, R. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0552 · Cited by 102
Tsang, J. Y. S., Tanriver, Y., Jiang, S., Leung, E. Y., Ratnasothy, K., Lombardi, G., & Lechler, R. I. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.05.003 · Cited by 80
Self-citationFOXP3: Genetic and epigenetic implications for autoimmunity
Katoh, H., Zheng, P., & Liu, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.004 · Cited by 76
Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls
Afzali, B., Edozie, F. C., Fazekasova, H., Scottà, C., Mitchell, P. J., Canavan, J. B., Kordasti, S. Y., Chana, P. S., Ellis, R., Lord, G. M., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12931212 · Cited by 74
Self-citationPromoting transplantation tolerance; adoptive regulatory T cell therapy
Safinia, N., Leech, J. M., Hernández-Fuentes, M. P., Lechler, R. I., & Lombardi, G. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12052 · Cited by 71
Self-citationRelevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
Sagoo, P., Lombardi, G., & Lechler, R. I. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00184 · Cited by 70
Self-citationLandwehr-Kenzel, S., Issa, F., Luu, S.-H., Schmück, M., Lei, H., Zobel, A., Thiel, A., Babel, N., Wood, K., Volk, H., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12629 · Cited by 68
Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells
Maher, J. (2012) · ISRN Oncology · doi:10.5402/2012/278093 · Cited by 67
Self-citationKrystufkova, E., Sekerková, A., Stříž, I., Brabcová, I., Girmanová, E., & Viklický, O. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr693 · Cited by 65
Jethwa, H., Adami, A. A., & Maher, J. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.11.004 · Cited by 63
Self-citationIL-6 Promotes Cardiac Graft Rejection Mediated by CD4+ Cells
Booth, A. J., Grabauskiene, S., Wood, S. C., Lu, G., Burrell, B. E., & Bishop, D. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100766 · Cited by 63
Hombach, A. A., Kofler, D. M., Hombach, A., Rappl, G., & Abken, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7924 · Cited by 55
Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
Boardman, D. A., Maher, J. F., Lechler, R. I., Smyth, L. A., & Lombardi, G. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150247 · Cited by 48
Self-citationPasquet, L., Douet, J., Sparwasser, T. D., Romagnoli, P., & van Meerwijk, J. P. M. (2013) · Blood · doi:10.1182/blood-2012-08-452037 · Cited by 31
CD31 Exhibits Multiple Roles in Regulating T Lymphocyte Trafficking In Vivo
Ma, L., Cheung, K. C.-P., Kishore, M., Nourshargh, S., Mauro, C., & Marelli‐Berg, F. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201739 · Cited by 30
Self-citationKrustrup, D., Madsen, C. B., Iversen, M., Engelholm, L. H., Ryder, L. P., & Andersen, C. B. (2013) · Transplant Immunology · doi:10.1016/j.trim.2013.08.002 · Cited by 18
Cited by
Regulatory T Cells and Human Disease
Sakaguchi, S., Mikami, N., Wing, J. B., Tanaka, A., Ichiyama, K., & Ohkura, N. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041717 · Cited by 1,120
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Morris, E. C., Neelapu, S. S., Giavridis, T., & Sadelain, M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00547-6 · Cited by 1,104
Therapeutic T cell engineering
Sadelain, M., Rivière, I., & Riddell, S. (2017) · Nature · doi:10.1038/nature22395 · Cited by 879
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Larson, R. C., & Maus, M. V. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00323-z · Cited by 852
Treg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Metadata
- Authors
- Boardman, D. A., Philippeos, C., Fruhwirth, G. O., Ibrahim, M. A. A., Hannen, R. F., Cooper, D., Marelli-Berg, F. M., Watt, F. M., Lechler, R. I., Maher, J., Smyth, L. A., & Lombardi, G.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 17
- Issue
- 4
- Pages
- 931-943
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2563656670
- Cited by
- 324
- References
- 57
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.